Biliary Tract Carcinoma — Trials

Biliary Tract Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 238
Recruiting: 138
Ph III recruiting: 9
Growth YoY: +12.7%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (111)

clinicaltrialsPublishedShowing 1–50 of 153 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07715903	Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy	not yet recruiting	Phase 1	20	National Cancer Institute (NCI)NIH	1	Sep 29, 2026	clinicaltrials
NCT04645160	Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers	recruiting	Phase 1 / Phase 2	31	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials